These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11596996)
21. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease]. Peleg L; Gazit E; Goldman B; Akstein E Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957 [No Abstract] [Full Text] [Related]
22. Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience. Kaback MM Prog Clin Biol Res; 1982; 103 Pt B():447-59. PubMed ID: 7163239 [No Abstract] [Full Text] [Related]
23. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960 [TBL] [Abstract][Full Text] [Related]
24. Prenatal testing for Tay-Sachs disease in the light of Jewish views regarding abortion. Baskin J Issues Health Care Women; 1983; 4(1):41-56. PubMed ID: 6553058 [No Abstract] [Full Text] [Related]
25. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Yamanaka S; Johnson MD; Grinberg A; Westphal H; Crawley JN; Taniike M; Suzuki K; Proia RL Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9975-9. PubMed ID: 7937929 [TBL] [Abstract][Full Text] [Related]
26. Tay-Sachs disease: Part 2. Model of a fatal, preventable, metabolic, genetic disorder. Hecht F; Anatole P; Szucs SC Ariz Med; 1984 Oct; 41(10):661-5. PubMed ID: 6508567 [No Abstract] [Full Text] [Related]
27. Ethical Issues with Genetic Testing for Tay-Sachs. Clayton T J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054 [TBL] [Abstract][Full Text] [Related]
28. The ovrselling of genetic anxiety. Goodman MJ; Goodman LE Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291 [TBL] [Abstract][Full Text] [Related]
30. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938 [TBL] [Abstract][Full Text] [Related]
31. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Zeesman S; Clow CL; Cartier L; Scriver CR Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173 [TBL] [Abstract][Full Text] [Related]
32. Role of the physician in screening for carriers of Tay-Sachs disease. Lowden JA Can Med Assoc J; 1978 Sep; 119(6):575-8. PubMed ID: 709448 [TBL] [Abstract][Full Text] [Related]
33. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Lacorazza HD; Flax JD; Snyder EY; Jendoubi M Nat Med; 1996 Apr; 2(4):424-9. PubMed ID: 8597952 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Tay-Sachs screening program on a college campus. Krischer JP; Savitt TL; Spring A; Wallace SE; Garnica AD; Frias JL South Med J; 1982 Feb; 75(2):169-74. PubMed ID: 7058357 [TBL] [Abstract][Full Text] [Related]
35. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene. Myerowitz R Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523 [TBL] [Abstract][Full Text] [Related]
36. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse. Tifft CJ; Proia RL Ann Med; 1997 Dec; 29(6):557-61. PubMed ID: 9562524 [TBL] [Abstract][Full Text] [Related]